BioCentury
ARTICLE | Clinical News

Aldoxorubicin: Completed Phase IIb enrollment

September 12, 2016 7:00 AM UTC

CytRx completed enrollment of 132 patients with SCLC who have relapsed or were refractory to prior chemotherapy in an open-label, international Phase IIb trial comparing 230 mg/m 2 IV aldoxorubicin gi...